Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup

Figure 2

(a) Color photograph of the left eye, 6 months after treatment with three monthly intravitreal injections of ranibizumab, showing subfoveal neurosensory detachment with macular subretinal hemorrhage. (c) and (d) The fluorescein angiograma shows the same nodular regions of hyperfluorescence associated with leakage as occult CNV. (b) ICGA image demonstrating typical hyperfluorescent polypoidal lesions at the fovea (white circle).